NCCN Guidelines for Patients® | Colon Cancer - page 86

NCCN Guidelines for Patients
®
Colon Cancer, Version 1.2014
84
Index
2
nd
opinion
73
ablation
25, 44
BRAF mutation
21
cancer staging
11–16, 35
carcinoembryonic antigen
21, 40, 45
carcinoma in situ
16
chemotherapy
25–29, 38–39, 42–44, 50–52, 57–65
clinical trial
30, 39, 58–59, 60–65
colectomy
24–25, 36, 38–39, 42–43
colonoscopy
19, 37, 40–41, 45
complementary and alternative medicine
31
complete blood count
21
computed tomography
20, 25, 40–41, 45
digestive tract
6–7
familial adenomatous polyposis
18
hereditary non-polyposis colon cancer
18
lymphadenectomy
25, 36, 38–39
Lynch syndrome
18, 41, 45
medical history
18, 40, 45
metastasectomy
25, 42–43, 50–51
polypectomy
12–13, 16, 36
polyps
8–9, 12, 18–19, 24, 35–37, 40–41, 45
radiation therapy
25, 39
RAS
21, 57–65
shared decision–making
68
targeted therapy
26, 28, 43–44, 57–65
Index
1...,76,77,78,79,80,81,82,83,84,85 87,88
Powered by FlippingBook